Document Classification

Section Type: RESULTS

Text: Significant reductions (p < 0. 05) in the mean values (baseline vs. 36 months) for the systolic blood pressure [156. 7 mmHg vs 133. 7 mmHg ; P < 0. 001), diastolic blood pressure (106. 6 mmHg vs. 91. 6 mmHg ; P < 0. 001), fasting glucose (135. 1 mg/dL vs. 107. 9 mg/dL ; P < 0. 001), hemoglobin A1C (7. 7 % vs. 7. 0 % ; P < 0. 001), triglycerides (206. 0 mg/dL vs. 152. 5 mg/dL ; P < 0. 001), low-density lipoprotein (LDL) cholesterol (112. 4 mg/dL vs. 102. 0 mg/dL ; P < 0. 001), high-density lipoprotein cholesterol (55. 5 mg/dL vs. 65. 5 mg/dL ; P < 0. 001), total cholesterol (202. 5 mg/dL vs. 185. 9 mg/dL ; P < 0. 001), body mass index (26. 2 kg/m2 vs. 26. 1 kg/m2 ; P < 0. 001), and abdominal circumference (103. 2 cm vs. 102. 5 cm ; P = 0. 001) were observed in the intervention group, whereas no significant changes were verified in the control group.